Canagliflozin is a C-glycosyl compound that functions as an inhibitor of sodium-glucose transport protein subtype 2. It is utilized as a hypoglycemic agent and is employed in pharmaceutical manufacturing for the management of type II diabetes.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 928672-86-0
Canagliflozin
active pharmaceutical ingredient
Seladelpar lysine
active pharmaceutical ingredient
Elinzanetant
non-hormonal NK-1 and NK-3 receptor antagonist
Dotarem
MRI contrast agent
구아이페네신
Expectorant active pharmaceutical ingredient
(1S)-2,3,4,6-Tetra-O-acetyl-1,5-anhydro-1-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-D-glucitol
pharmaceutical intermediate
D-Glucitol, 1,5-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-, 2,3,4,6-tetrakis(2,2-dimethylpropanoate), (1S)-
research compound
(2S,3R,4R,5S,6R)-2-[3-[[5-(4-fluorophenyl)thiophen-2-yl]methyl]-4-methylphenyl]-6-(hydroxymethyl)oxane-3,4,5-triol
XTNGUQKDFGDXSJ-ZXGKGEBGSA-N
CC1=C(C=C(C=C1)[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)CC3=CC=C(S3)C4=CC=C(C=C4)F